Inactive Ingredient Search for Approved Drug Products
You are Searching: Change and Deletion by Inactive Ingredient Name Beginning with H
| Quarter | Inactive Ingredient | Route of Administration | Dosage Form | Maximum Potency per unit dose | Maximum Daily Exposure | Status | |
|---|---|---|---|---|---|---|---|
| Q1 2024 | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | ORAL | CAPSULE, EXTENDED RELEASE | 214mg | Correction | ||
| Q2 2024 | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | ORAL | CAPSULE, EXTENDED RELEASE | 204mg | Correction | ||
| Q1 2024 | HYPROMELLOSE 2910 (4000 MPA.S) | OPHTHALMIC | GEL | 197mg | Correction | ||
| Q2 2024 | HYPROMELLOSE 2910 (4000 MPA.S) | OPHTHALMIC | GEL | 1mg | Correction | ||
| Q2 2024 | HYDROCHLORIC ACID | INTRAVENOUS | POWDER, FOR SOLUTION | ADJ PH | Deletion | ||
| Q2 2024 | HYPROMELLOSE | NASAL | SPRAY | 1.00 mg/ 1.00 ml | 1mg | Deletion | |
| Q2 2024 | HYPROMELLOSE | ORAL | SOLUTION | 3.70 mg/ 1.00 ml | Deletion | ||
| Q1 2024 | HYDROXYETHYL CELLULOSE (4000 MPA.S AT 1%) | OPHTHALMIC | SOLUTION/ DROPS | 0.48 %w/v | MDE Replacement | ||
| Q2 2024 | HYDROXYETHYL CELLULOSE (4000 MPA.S AT 1%) | OPHTHALMIC | SOLUTION/ DROPS | 1mg | MDE Replacement | ||
| Q1 2024 | HYPROMELLOSE 2208 (15000 MPA.S) | ORAL | TABLET | 323.28 mg | MDE Replacement | ||
| Q2 2024 | HYPROMELLOSE 2208 (15000 MPA.S) | ORAL | TABLET | 375mg | MDE Replacement |
FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections: IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly
Data Through: March 15, 2024
Database Last Updated: April 29, 2024